CC003
A Randomized Phase II/III Trial of Prophylactic Cranial Irradiation with or without Hippocampal Avoidance for Small Cell Lung Cancer
Trial overview
Disease | Lung cancer treatment and diagnosis |
Topic | CC003 |
Description | Primary Objective:To determine whether the 12-month intracranial relapse rate following HA-PCI is non-inferior compared to the rate following PCI for patients with SCLC. To determine whether HA-PCI reduces the likelihood of 6-month deterioration from baseline in HVLT-R delayed recall compared to the PCI for patients with SCLC.Patient Population:Histologic proof or unequivocal cytologic proof (fine needle aspiration, biopsy or two positive sputa) of SCLC within 250 days prior to Step 1 registration; Zubrod performance status 0-2; Patients who are primary English or French speakers are eligible. |
Physicians | Dr. Alvaro A. MartinezMD, FACR, FABS, FASTRO Radiation Oncologist Works at 5 centers.Dr. Frank A. ViciniMD, FACR, FASTRO Radiation oncologist Works at 3 centers.Dr. Larry L. KestinMD, FACR Radiation Oncologist Works at 3 centers.Dr. Thomas BoikeMD Radiation Oncologist Works at 3 centers.Dr. Michael I. GhilezanMD, PhD Radiation Oncologist Works at 4 centers.Dr. John Vito AntonucciMD Radiation Oncologist Works at 4 centers. |
Location | Warning: count(): Parameter must be an array or an object that implements Countable in /var/www/html/wp-content/themes/genesiscare/src/components/hcp_clinical_trial_heading/hcp_clinical_trial_heading.php on line 299 Warning: Invalid argument supplied for foreach() in /var/www/html/wp-content/themes/genesiscare/src/components/hcp_clinical_trial_heading/hcp_clinical_trial_heading.php on line 301 |